文献速递血液淋巴病理细胞病理与分子病理

生成式人工智能在临床病理实践中的应用评估:机遇与前行路径

Evaluating Use of Generative Artificial Intelligence in Clinical Pathology Practice: Opportunities and the Way Forward.
PubMed 文献 · Arch Pathol Lab Med · 2025-01-01

该综述回顾了生成式人工智能(GAI)在临床病理(CP)中的应用场景,重点讨论大语言模型在临床化学、微生物学、血液病理学和分子诊断等亚专科中的用例,并评估其潜在陷阱。结论认为GAI有潜力革新医疗保健,但需谨慎实施以应对偏见、幻觉、工作流程整合挑战及终端用户接受度等问题,人机协同模式有望深化对患者结局的洞察。

要点

  • GAI在临床病理的应用包括教育、数据挖掘、决策支持、结果摘要和患者趋势评估。
  • 实施GAI需警惕偏见、幻觉、工作流程整合困难及终端用户接受度等挑战。
  • 人机协同模式有望在个体和群体层面深化对患者结局的洞察。

核心结论

  • GAI是强大工具,有潜力革新患者和从业者的医疗保健,但必须谨慎实施以应对技术短板。
  • 人机协同的GAI实施模式有望通过提供更深入、有意义的患者结局洞察来革新临床病理。

研究设计与样本

  • 综述类文章,广泛回顾当前关于GAI在医疗保健中应用的文献。
  • 针对临床化学、微生物学、血液病理学和分子诊断等临床病理亚专科,评估常见数据源在GAI情境下的利用潜力。

主要发现

  • GAI在临床病理的应用涵盖教育、数据挖掘、决策支持、结果摘要和患者趋势评估。
  • 需关注未来报告范式、对质量指标的影响以及转化研究活动的潜力。
  • GAI技术存在偏见、幻觉、在现有临床病理工作流程中实施的实际挑战以及终端用户接受度等不足。

临床怎么用

  • 临床病理实践可探索GAI在教育、数据挖掘、决策支持、结果摘要和患者趋势评估中的应用。
  • 实施GAI时应采用人机协同模式,并充分考虑偏见、幻觉、工作流程整合和用户接受度等问题。

局限性

  • GAI技术存在偏见、幻觉等固有不足。
  • 在现有临床病理工作流程中实施GAI面临实际挑战。
  • 终端用户对GAI的接受度是实施中的潜在障碍。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT.—: Generative artificial intelligence (GAI) technologies are likely to dramatically impact health care workflows in clinical pathology (CP). Applications in CP include education, data mining, decision support, result summaries, and patient trend assessments. OBJECTIVE.—: To review use cases of GAI in CP, with a particular focus on large language models. Specific examples are provided for the applications of GAI in the subspecialties of clinical chemistry, microbiology, hematopathology, and molecular diagnostics. Additionally, the review addresses potential pitfalls of GAI paradigms. DATA SOURCES.—: Current literature on GAI in health care was reviewed broadly. The use case scenarios for each CP subspecialty review common data sources generated in each subspecialty. The potential for utilization of CP data in the GAI context was subsequently assessed, focusing on issues such as future reporting paradigms, impact on quality metrics, and potential for translational research activities. CONCLUSIONS.—: GAI is a powerful tool with the potential to revolutionize health care for patients and practitioners alike. However, GAI must be implemented with much caution considering various shortcomings of the technology such as biases, hallucinations, practical challenges of implementing GAI in existing CP workflows, and end-user acceptance. Human-in-the-loop models of GAI implementation have the potential to revolutionize CP by delivering deeper, meaningful insights into patient outcomes both at an individual and a population level.

来源:Arch Pathol Lab Med,查看原文。版权归原作者所有。

引用

  1. McCaffrey P, Jackups R, Seheult J, et al. Evaluating Use of Generative Artificial Intelligence in Clinical Pathology Practice: Opportunities and the Way Forward. Arch Pathol Lab Med. 2025. PMID: 39384182. doi:10.5858/arpa.2024-0208-RA

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。